Related Experiment Video

Updated: Jan 18, 2026

Author Spotlight: Purifying High-Quality Tubulin to Study Protein Dynamics and Therapeutic Applications
06:30

Author Spotlight: Purifying High-Quality Tubulin to Study Protein Dynamics and Therapeutic Applications

Published on: October 11, 2024

2.3K

Verubulin and its derivatives: Progress and promise in tubulin-targeted cancer therapy

Alireza Mousavi1, Mahfam Moradi1, Loghman Firoozpour2

  • 1Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

European Journal of Medicinal Chemistry
|September 12, 2025
PubMed

Insights

Verubulin is a promising anticancer drug targeting microtubules for glioblastoma treatment. Ongoing research optimizes its derivatives for improved efficacy, brain penetration, and potential use as a diagnostic imaging agent.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Verubulin (MPC-6827) is a microtubule-destabilizing agent targeting the colchicine site on tubulin.
  • It has shown efficacy in glioblastoma and multidrug-resistant cancers by inducing mitotic arrest.

Purpose of the Study:

  • To review the pharmacological profile, clinical development, and structural evolution of verubulin-based compounds.
  • To highlight verubulin's role in advancing tubulin-targeting cancer therapies.
  • To discuss future perspectives for verubulin derivatives in oncology and diagnostics.

Main Methods:

  • Comprehensive literature review of verubulin and its derivatives.
  • Analysis of pharmacological data, clinical trial outcomes, and structural modifications.
  • Exploration of diagnostic applications based on molecular properties.

Main Results:

  • Verubulin derivatives have been optimized for enhanced potency, selectivity, metabolic stability, and brain penetration.
  • Verubulin's mechanism involves interfering with microtubule dynamics and inducing cell cycle arrest.
  • Its properties also support its use as a brain-targeted molecular imaging agent.

Conclusions:

  • Verubulin represents a valuable scaffold for next-generation anticancer agents, particularly in neuro-oncology.
  • Further development of verubulin derivatives holds promise for improved therapeutic and diagnostic applications.
  • New verubulin-based candidates may soon enter clinical evaluation.
Keywords:
CBSColchicine binding site inhibitorsTubulinVerubulin

More Related Videos

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

3.1K
Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins08:13

Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins

Published on: November 30, 2021

2.8K

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K